Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis Inc. projects substantial growth in key revenue streams, with forecasts for FY26E indicating a 24% increase in systems revenue to $43M, a 20% rise in disposables to $12M, and a 25% increase in recurring revenue to $31M, driven by the adoption of new systems and continued utilization of catheters. In its most recent quarter, the company demonstrated strong financial performance, reporting a 95% year-over-year revenue increase to $8.8M and robust recurring revenue growth of 35% to $5.8M, underscoring the impact of new product launches such as the Map-iT and MAGiC ablation catheters. Furthermore, Stereotaxis has achieved significant regulatory milestones, positioning itself for enhanced market leverage with the anticipated launches of next-generation robotic and mapping catheters, thus supporting its outlook for double-digit revenue growth leading into FY26.

Bears say

Stereotaxis Inc. is facing a challenging financial landscape, highlighted by a net loss of $3.8 million and a cash runway of only two years, indicating potential liquidity issues unless additional financing is secured. Operating expenses have shown a slight decrease; however, ongoing supply challenges, delays in new product approvals, and reimbursement rate reductions pose significant risks to revenue generation and profitability. Additionally, the competitive environment from manual and alternative robotic systems further complicates the company’s ability to capture market share and achieve its financial targets.

Stereotaxis Inc (STXS) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 2 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.